https://pravastatininhibitor.c....om/antifungal-suscep
The liver, a target for S-3100-CA via transporters, engages in its elimination through biliary excretion and metabolic processes. Our prior human PBPK research successfully forecast S-3100-CA pharmacokinetics by utilizing hepatic parameters isolated from chimeric mice. These chimeric mice exhibited humanized livers, and the resultant model's performance was measured quantitatively using data fro
Curtir
Comentario
Compartilhar
